Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

2.
3.

Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.

Martel CL, Mackic JB, Matsubara E, Governale S, Miguel C, Miao W, McComb JG, Frangione B, Ghiso J, Zlokovic BV.

J Neurochem. 1997 Nov;69(5):1995-2004.

4.

Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.

Zlokovic BV, Martel CL, Mackic JB, Matsubara E, Wisniewski T, McComb JG, Frangione B, Ghiso J.

Biochem Biophys Res Commun. 1994 Dec 15;205(2):1431-7.

PMID:
7802679
5.

Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs.

Martel CL, Mackic JB, McComb JG, Ghiso J, Zlokovic BV.

Neurosci Lett. 1996 Mar 15;206(2-3):157-60.

PMID:
8710175
6.

Apolipoprotein J and Alzheimer's amyloid beta solubility.

Matsubara E, Soto C, Governale S, Frangione B, Ghiso J.

Biochem J. 1996 Jun 1;316 ( Pt 2):671-9.

7.

Apolipoprotein J (clusterin) and Alzheimer's disease.

Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, Ghiso J.

Microsc Res Tech. 2000 Aug 15;50(4):305-15. Review.

PMID:
10936885
9.

Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid.

Golabek A, Marques MA, Lalowski M, Wisniewski T.

Neurosci Lett. 1995 May 19;191(1-2):79-82.

PMID:
7659297
10.

Characterization of apolipoprotein J-Alzheimer's A beta interaction.

Matsubara E, Frangione B, Ghiso J.

J Biol Chem. 1995 Mar 31;270(13):7563-7.

11.

Blood-brain barrier transport of circulating Alzheimer's amyloid beta.

Zlokovic BV, Ghiso J, Mackic JB, McComb JG, Weiss MH, Frangione B.

Biochem Biophys Res Commun. 1993 Dec 30;197(3):1034-40.

PMID:
8280117
12.

Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy.

Mackic JB, Weiss MH, Miao W, Kirkman E, Ghiso J, Calero M, Bading J, Frangione B, Zlokovic BV.

J Neurochem. 1998 Jan;70(1):210-5.

13.
14.

Apolipoprotein E and amyloidogenesis.

Frangione B, CastaƱo EM, Wisniewski T, Ghiso J, Prelli F, Vidal R.

Ciba Found Symp. 1996;199:132-41; discussion 141-5.

PMID:
8915608
16.

Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.

Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM.

J Neurosci. 2005 Mar 16;25(11):2803-10.

17.

Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.

Cole GM, Ard MD.

Microsc Res Tech. 2000 Aug 15;50(4):316-24. Review.

PMID:
10936886
18.

Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.

Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV.

Vascul Pharmacol. 2002 Jun;38(6):303-13.

PMID:
12529925
19.

Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid.

Olesen OF, Mikkelsen JD, Gerdes C, Jensen PH.

Brain Res Mol Brain Res. 1997 Feb;44(1):105-12.

PMID:
9030704
20.

Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid.

LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT.

J Biol Chem. 1995 Apr 21;270(16):9039-42.

Items per page

Supplemental Content

Write to the Help Desk